DIR fees

Pharmacy coalition praises legislation to relieve patients and pharmacies from pharmacy DIR fees

Pharmacy coalition praises legislation to relieve patients and pharmacies from pharmacy DIR fees

WASHINGTON – With pharmacy access top-of-mind due to the pandemic and with drug- pricing concerns remaining a national policy priority, organizations representing pharmacies and pharmacists are lauding legislation to confront the serious issue of pharmacy direct and indirect remuneration (DIR) fees. The organizations stated: “DIR fees are exerting unnecessary and devastating pressures on patients, on

Credit NCPA for suing to eradicate DIR fees

Credit NCPA for suing to eradicate DIR fees

After several years of unsuccessful efforts by pharmacy advocates to persuade members of Congress and the executive branch to put an end to inequities in direct and indirect remuneration under Medicare Part D, the National Community Pharmacists Association is taking the fight to court. NCPA last month filed a lawsuit against the Department of Health

Pharmacy groups say new rebate rule does not do enough to support patients

Pharmacy groups say new rebate rule does not do enough to support patients

ALEXANDRIA, Va. – The country’s leading pharmacy groups issued the following statement on the Trump administration’s new final rule on prescription drug rebates: “While we want our patients to pay less for their prescription drugs, this rule does not accomplish that. It will likely increase their insurance premiums and out-of-pocket costs, and may limit patients’ access

Pharmacy groups tell HHS that any action on rebate rule must involve fixing pharmacy DIR fees

Pharmacy groups tell HHS that any action on rebate rule must involve fixing pharmacy DIR fees

ALEXANDRIA, Va. – The country’s leading pharmacy groups said that any action on a prescription drug rebate rule must address skyrocketing fees extracted by pharmacy benefit managers on behalf of plan sponsors in Medicare Part D. “We remind the Administration of the continuous and heightened impact of pharmacy DIR fees imposed by Medicare Part D

NCPA CEO to Trump: Fix DIR fees to lower drug costs

NCPA CEO to Trump: Fix DIR fees to lower drug costs

ALEXANDRIA, Va. — In a letter to President Trump, National Community Pharmacists Association CEO B. Douglas Hoey says that as part of any efforts on drug pricing, the administration must eliminate back-door fees that insurance companies use to increase drug costs for seniors and gouge local pharmacies. “Insurance companies are using their prescription drug management divisions

More than 240 patient, health care groups urge congress to reform pharmacy “DIR fees” this year

More than 240 patient, health care groups urge congress to reform pharmacy “DIR fees” this year

WASHINGTON – More than 240 patient advocates and healthcare entities on Friday urged Congressional leaders to act now on a key reform to lower patients’ prescription drug prices at the pharmacy counter and to help prevent pharmacy closures that jeopardize access for vulnerable Americans. “Members of Congress should not overlook the clear and present opportunity to

No quick relief from reimbursement burden

No quick relief from reimbursement burden

A new report on the cost of dispensing prescription medications brings into sharp focus the difficult economic challenges faced by retail pharmacy operators. It should come as no surprise that the study — conducted by Abt Associates and the MPI Group for the National Association of Chain Drug Stores, the National Community Pharmacists Association and

NACDS op-ed in Morning Consult: DIR fees “as damaging to patients and pharmacies as advertised”

NACDS op-ed in Morning Consult: DIR fees “as damaging to patients and pharmacies as advertised”

ARLINGTON, Va. – Morning Consult Wednesday published an op-ed by NACDS president and chief executive officer Steven Anderson that tells Congress just how critical it is for the wellbeing of patients and pharmacies to enact relief from direct and indirect remuneration (DIR) fees. “A simple truth is emerging about the complex topic known as pharmacy DIR fees: they

NACDS: Congress must act now to reduce costs

NACDS: Congress must act now to reduce costs

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is welcoming the strongest signal yet by the Centers for Medicare & Medicaid Services (CMS) that a standardized pharmacy quality program should be created to help reduce patients’ out-of-pocket drug costs and to help patients maintain critical access to their pharmacies. Currently, quality measures

Senate Finance Committee wages bipartisan effort to lower DIR fees

Senate Finance Committee wages bipartisan effort to lower DIR fees

ARLINGTON, Va. — On a strong bipartisan basis, the chairman, ranking member, and an overwhelming majority of the Senate Finance Committee have asked the Trump Administration to do its part to close a Medicare regulation loophole – known as pharmacy direct and indirect remuneration (DIR) fees – that inflates patients’ out-of-pocket drug costs and that

NCPA urges PBM reform in major media print ads

NCPA urges PBM reform in major media print ads

ALEXANDRIA, Va. — In print ads Tuesday in the Washington Post and the Wall Street Journal, the National Community Pharmacists Association is urging policymakers to rein in pharmacy benefit managers to help lower drug costs. These ads complement NCPA’s ongoing efforts in its years-long campaign to reform pharmacy direct and indirect remuneration (DIR) fees, a

1 2 3